About

Technology

Publications

Team

Contact

A New Standard
in Bacterial Diagnostics

A New Standard
in Bacterial Diagnostics

A New Standard
in Bacterial Diagnostics

The R2 System uses proprietary universal PCR and machine learning to identify bacterial pathogens directly from clinical samples—no culture, no guesswork. Our platform delivers species-level results in under 3 hours, enabling precise treatment when it matters most.

The R2 System uses proprietary universal PCR and machine learning to identify bacterial pathogens directly from clinical samples—no culture, no guesswork. Our platform delivers species-level results in under 3 hours, enabling precise treatment when it matters most.

How it Works

The R2 System targets highly variable internal transcribed spacer (ITS) regions between conserved bacterial genes using a proprietary set of universal primers.

Each pathogen generates a unique fingerprint, which is analyzed by our machine learning algorithm to deliver species-level identification—without requiring prior pathogen knowledge or culture enrichment. From whole blood or other clinical samples, the system extracts DNA, performs PCR, and analyzes the result—all within a streamlined workflow optimized for clinical labs.

The R2 System targets highly variable internal transcribed spacer (ITS) regions between conserved bacterial genes using a proprietary set of universal primers.

Each pathogen generates a unique fingerprint, which is analyzed by our machine learning algorithm to deliver species-level identification—without requiring prior pathogen knowledge or culture enrichment. From whole blood or other clinical samples, the system extracts DNA, performs PCR, and analyzes the result—all within a streamlined workflow optimized for clinical labs.

Platform Advantages

Culture-Free

Detects pathogens directly from sample

Hypothesis-Free

Does not require a priori knowledge or utilize predefined primer sets

Rapid Turnaround

Provides actionable results in under 3 hours, supporting more rapid therapeutic decision-making.

Quantitative

Provides estimated bacterial concentration to help distinguish infection from contamination or colonization

Clinically Integrated

Designed for compatibility with existing lab workflows and minimal user training.

Supports Antimicrobial Stewardship

Enables targeted therapy or rapid deescalation to reduce unnecessary broad-spectrum antibiotic use.

Why Pyogenix?

Improved
Patient Outcomes

Decreases patient morbidity and mortality

Optimized Healthcare Efficiency

Reduces patient costs and average hospital lengths of stay

© Pyogenix 2020

Create a free website with Framer, the website builder loved by startups, designers and agencies.